Table 2.
N* | OR | 95% CI | P | I2(%) | OR | 95% CI | P | I2(%) | OR | 95% CI | P | I2(%) | OR | 95% CI | P | I2(%) | OR | 95% CI | P | I2(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
rs671 | A vs. G | GA vs. GG | AA vs. GG | GA+AA vs. GG | AA vs. GG+GA | ||||||||||||||||
AD Total | 6 | 1.46 | 1.01–2.11 | 0.05 | 84.2 | 1.35 | 0.91–1.99 | 0.13 | 73.9 | 2.22 | 1.03–4.77 | 0.04 | 79.2 | 1.36 | 0.90–2.03 | 0.14 | 81.0 | 1.94 | 1.03–3.64 | 0.04 | 71.1 |
HWE–yes | 4 | 1.48 | 0.88–2.49 | 0.14 | 87.4 | 1.26 | 0.72–2.21 | 0.41 | 79.4 | 2.57 | 1.01–6.53 | 0.05 | 78.1 | 1.45 | 0.77–2.73 | 0.25 | 86.0 | 2.23 | 1.18–4.60 | 0.01 | 61.4 |
HWE–no | 2 | 1.36 | 1.10–1.69 | 0.01 | NA | 1.60 | 1.21–2.12 | 0.001 | NA | 1.33 | 0.78–2.27 | 0.29 | NA | 1.19 | 0.64–2.18 | 0.58 | 76.4 | 1.11 | 0.66–1.87 | 0.69 | NA |
COUNTRY | |||||||||||||||||||||
China | 3 | 1.64 | 0.87–3.10 | 0.12 | 88.3 | 1.39 | 0.67–2.85 | 0.38 | 83.0 | 3.15 | 1.03–9.65 | 0.04 | 79.6 | 1.63 | 0.74–3.62 | 0.23 | 87.9 | 2.75 | 1.23–6.14 | 0.02 | 63.0 |
Japan | 2 | 1.54 | 1.00–2.36 | 0.05 | 17.1 | 1.28 | 0.77–2.13 | 0.33 | 69.7 | 1.34 | 0.85–2.12 | 0.20 | 0 | 1.31 | 0.87–1.98 | 0.20 | 59.6 | 1.18 | 0.76–1.85 | 0.46 | 0 |
CONTROL DESIGN | |||||||||||||||||||||
HB | 4 | 1.57 | 1.02–2.42 | 0.04 | 86.0 | 1.47 | 0.95–2.27 | 0.09 | 74.6 | 2.48 | 0.98–6.30 | 0.06 | 83.4 | 1.63 | 0.99–2.67 | 0.05 | 82.7 | 2.10 | 0.96–357 | 0.06 | 77.6 |
PB | 2 | 1.07 | 0.75–1.54 | 0.71 | NA | 0.95 | 0.58–1.55 | 0.84 | NA | 1.38 | 0.57–3.35 | 0.48 | NA | 0.93 | 0.65–1.32 | 0.68 | 0 | 1.41 | 0.60–3.34 | 0.43 | NA |
SUBJECTS | |||||||||||||||||||||
>500 | 2 | 1.36 | 1.10–1.69 | 0.01 | NA | 1.60 | 1.21–2.12 | 0.001 | NA | 1.33 | 0.78–2.27 | 0.29 | NA | 1.19 | 0.64–2.18 | 0.58 | 76.4 | 1.11 | 0.66–1.87 | 0.69 | NA |
< 500 | 4 | 1.48 | 0.88–2.49 | 0.14 | 87.4 | 1.26 | 0.72–2.21 | 0.41 | 79.4 | 2.57 | 1.01–6.53 | 0.05 | 78.1 | 1.45 | 0.77–2.73 | 0.25 | 86.0 | 2.23 | 1.18–4.60 | 0.01 | 61.4 |
NOS EVALUATION | |||||||||||||||||||||
NOS < 8 | 5 | 1.57 | 1.02–2.42 | 0.04 | 86.0 | 1.47 | 0.95–2.27 | 0.09 | 74.6 | 2.48 | 0.98–6.30 | 0.06 | 83.4 | 1.43 | 0.90–2.28 .92–2.18 | 0.13 | 82.9 | 2.10 | 0.96–357 | 0.06 | 77.6 |
NOS ≥8 | 1 | 1.07 | 0.75–1.54 | 0.71 | NA | 0.95 | 0.58–1.55 | 0.84 | NA | 1.38 | 0.57–3.35 | 0.748 | NA | 1.01 | 0.64–1.61 | 0.96 | NA | 1.41 | 0.60–3.34 | 0.43 | NA |
GENDER | |||||||||||||||||||||
Male | 2 | 1.52 | 1.06–2.16 | 0.02 | 0 | 1.70 | 1.07–2.70 | 0.03 | 14.3 | 1.81 | 0.73–4.46 | 0.20 | 0 | 1.72 | 1.10–2.67 | 0.02 | 0 | 1.47 | 0.60–3.58 | 0.40 | 0 |
Female | 2 | 0.90 | 0.40–2.10 | 0.79 | 83.4 | 0.94 | 0.35–2.57 | 0.891 | 81.5 | 0.93 | 0.37–2.32 | 0.88 | 43.8 | 0.91 | 0.33–1.2.49 | 0.86 | 84.3 | 0.98 | 0.57–1.69 | 0.95 | 0 |
PD Total | 2 | 1.38 | 0.77–2.45 | 0.28 | 85.2 | 1.23 | 0.98–1.52 | 0.07 | 0 | 1.95 | 0.31–12.23 | 0.47 | 89.3 | 1.30 | 0.90–1.92 | 0.15 | 53.6 | 1.18 | 0.29–11.16 | 0.52 | 89.4 |
Rs4767944 | T vs. C | CT vs. CC | TT vs. CC | CT+TT vs. CC | TT vs. CC+CT | ||||||||||||||||
PD Total | 2 | 0.87 | 0.67–1.14 | 0.31 | 70.9 | 0.89 | 0.58–1.36 | 0.60 | 71.3 | 0.57 | 0.40–0.80 | < 0.01 | 0 | 0.83 | 0.51–1.36 | 0.46 | 80.3 | 0.71 | 0.56–0.90 | 0.01 | 0 |